Charles Bennett to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications Charles Bennett has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.040
-
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology. Blood. 1999 Sep 01; 94(5):1517-36.
Score: 0.040